Glutamine is a nonessential amino acid, which under trauma or critical illness can become essential. A number of historic small single-center randomized controlled trials (RCTs) have demonstrated positive treatment effects on clinical outcomes with glutamine supplementation. Meta-analyses based on these trials demonstrated a significant reduction in hospital mortality, intensive care unit (ICU) length of stay (LOS), and hospital LOS with intravenous (IV) glutamine. Similar results were not noted in 2 large multicenter RCTs (REDOXS and MetaPlus) assessing the efficacy of glutamine supplementation in ventilated ICU patients. The REDOXS trial of 40 ICUs randomized 1223 ventilated ICU patients to glutamine (IV and enteral), antioxidants, both glutamine and antioxidants, or placebo. The main conclusions were a trend toward increased 28-day mortality and significant increased hospital and 6-month mortality in those who received glutamine. The MetaPlus trial of 14 ICUs, which randomized 301 ventilated ICU patients to glutamine-enriched enteral vs an isocaloric diet, noted increased 6-month mortality in the glutamine-supplemented group. Newer RCTs have focused on specific populations and have demonstrated benefits in burn and elective surgery patients with glutamine supplementation. Whether larger studies will confirm these findings is yet to be determined. Recent American Society for Parenteral and Enteral Nutrition guidelines recommend that IV and enteral glutamine should not be used in the critical care setting based on the moderate quality of evidence available. We agree with these recommendations and would encourage larger multicenter studies to evaluate the risks and benefits of glutamine in burn and elective surgery patients.
CoëffierMDéchelotteP. The role of glutamine in intensive care unit patients: mechanisms of action and clinical outcome. Nutr Rev. 2005;63(2):65-69.
2.
WatfordM. Glutamine metabolism and function in relation to proline synthesis and the safety of glutamine and proline supplementation. J Nutr. 2008;138(10):2003S-2007S.
3.
WatfordMReedsPJ. Glutamate metabolism in the gut. Forum Nutr. 2003;56:81-82.
4.
WindmuellerHGSpaethAE. Uptake and metabolism of plasma glutamine by the small intestine. J Biol Chem. 1974;249(16):5070-5079.
5.
WasinskiFGregnaniMFOrnellasFH. Lymphocyte glucose and glutamine metabolism as targets of the anti-inflammatory and immunomodulatory effects of exercise. Mediators Inflamm. 2014;2014:326803.
6.
CuriRNewsholmePPithon-CuriTC. Metabolic fate of glutamine in lymphocytes, macrophages and neutrophils. Braz J Med Biol Res. 1999;32(1):15-21.
7.
WilmoreDWShabertJK. Role of glutamine in immunologic responses. Nutrition. 1998;14(7-8):618-626.
8.
BrandKLeiboldWLuppaPSchoernerCSchulzA. Metabolic alterations associated with proliferation of mitogen-activated lymphocytes and of lymphoblastoid cell lines: evaluation of glucose and glutamine metabolism. Immunobiology. 1986;173(1):23-34.
9.
Parry-BillingsMCalderPCNewsholmeEAEvansJ. Does glutamine contribute to immunosuppression after major burns?Lancet. 1990;336(8714):523-525.
10.
OgleCKOgleJDMaoJX. Effect of glutamine on phagocytosis and bacterial killing by normal and pediatric burn patient neutrophils. JPEN J Parenter Enteral Nutr. 1994;18(2):128-133.
11.
SpittlerAWinklerSGotzingerP. Influence of glutamine on the phenotype and function of human monocytes. Blood. 1995;86(4):1564-1569.
12.
JureticASpagnoliGCHörigH. Glutamine requirements in the generation of lymphokine-activated killer cells. Clin Nutr. 1994;13(1):42-49.
13.
McClaveSATaylorBEMartindaleRG. Guidelines for the provision and assessment of nutrition support therapy in the adult critically ill patient: Society of Critical Care Medicine (SCCM) and American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.). J Parenter Enteral Nutr. 2016;40(2):159-211.
14.
WattersJMBesseyPQDinarelloCAWolffSMWilmoreDW. Both inflammatory and endocrine mediators stimulate host responses to sepsis. Arch Surg. 1986;121(2):179-190.
15.
StreatSJBeddoeAHHillGL. Aggressive nutritional support does not prevent protein loss despite fat gain in septic intensive care patients. J Trauma. 1987;27(3):262-266.
16.
MuhlbacherFKapadiaCRColpoysMFSmithRJWilmoreDW. Effects of glucocorticoids on glutamine metabolism in skeletal muscle. Am J Physiol. 1984;247(1, pt 1):E75-E83.
17.
BlomqvistBIHammarqvistFvon der DeckenAWernermanJ. Glutamine and alpha-ketoglutarate prevent the decrease in muscle free glutamine concentration and influence protein synthesis after total hip replacement. Metabolism. 1995;44(9):1215-1222.
18.
Parry-BillingsMBaigrieRJLamontPMMorrisPJNewsholmeEA. Effects of major and minor surgery on plasma glutamine and cytokine levels. Arch Surg. 1992;127(10):1237-1240.
JianZMCaoJDZhuXG. The impact of alanyl-glutamine on clinical safety, nitrogen balance, intestinal permeability, and clinical outcome in postoperative patients: a randomized, double-blind, controlled study of 120 patients. JPEN J Parenter Enteral Nutr. 1999;23(5)(suppl):S62-S66.
23.
GoetersCWennAMertesN. Parenteral L-alanyl-L-glutamine improves 6-month outcome in critically ill patients. Crit Care Med. 2002;30(9):2032-2037.
24.
ZhouY-PJiangZ-MSunY-HWangX-RMaE-LWilmoreD. The effect of supplemental enteral glutamine on plasma levels, gut function, and outcome in severe burns: a randomized, double-blind, controlled clinical trial. JPEN J Parenter Enteral Nutr. 2003;27(4):241-245.
25.
MorrisonALDingesMSingletonKDOdomsKWongHRWischmeyerPE. Glutamine’s protection against cellular injury is dependent on heat shock factor-1. Am J Physiol Cell Physiol. 2006;290(6):C1625-C1632.
26.
ZieglerTROgdenLGSingletonKD. Parenteral glutamine increases serum heat shock protein 70 in critically ill patients. Intensive Care Med. 2005;31(8):1079-1086.
27.
PengXYanHYouZWangPWangS. Effects of enteral supplementation with glutamine granules on intestinal mucosal barrier function in severe burned patients. Burns J. 2004;30(2):135-139.
28.
van der HulstRRvan KreelBKvon MeyenfeldtMF. Glutamine and the preservation of gut integrity. Lancet. 1993;341(8857):1363-1365.
29.
NoyerCMSimonDBorczukABrandtLJLeeMJNehraV. A double-blind placebo-controlled pilot study of glutamine therapy for abnormal intestinal permeability in patients with AIDS. Am J Gastroenterol. 1998;93(6):972-975.
30.
HondEDHieleMPeetersMGhoosYRutgeertsP. Effect of long-term oral glutamine supplements on small intestinal permeability in patients with Crohn’s disease. JPEN J Parenter Enteral Nutr. 1999;23(1):7-11.
31.
KlesKATappendenKA. Hypoxia differentially regulates nutrient transport in rat jejunum regardless of luminal nutrient present. Am J Physiol Gastrointest Liver Physiol. 2002;283(6):G1336-G1342.
32.
McQuigganMKozarRSailorsRMAhnCMcKinleyBMooreF. Enteral glutamine during active shock resuscitation is safe and enhances tolerance of enteral feeding. JPE J Parenter Enteral Nutr. 2008;32(1):28-35.
33.
KazamiasPKotzampassiKKoufogiannisDEleftheriadisE. Influence of enteral nutrition–induced splanchnic hyperemia on the septic origin of splanchnic ischemia. World J Surg. 1998;22(1):6-11.
34.
MathesonPJSpainDAHarrisPDGarrisonRNWilsonMA. Glucose and glutamine gavage increase portal vein nitric oxide metabolite levels via adenosine A2b activation. J Surg Res. 1999;84(1):57-63.
35.
PengZBanKWawroseRAGoverAGKozarRA. Protection by enteral glutamine is mediated by intestinal epithelial cell peroxisome proliferator–activated receptor-γ during intestinal ischemia/reperfusion. Shock. 2015;43(4):327-333.
36.
SatoNMooreFAKoneBC. Differential induction of PPAR-gamma by luminal glutamine and iNOS by luminal arginine in the rodent postischemic small bowel. Am J Physiol Gastrointest Liver Physiol. 2006;290(4):G616-G623.
37.
JolfaieNRMirzaieSGhiasvandRAskariGMiraghajaniM. The effect of glutamine intake on complications of colorectal and colon cancer treatment: a systematic review. J Res Med Sci. 2015;20(9):910-918.
38.
O’RiordainMGFearonKCRossJA. Glutamine-supplemented total parenteral nutrition enhances T-lymphocyte response in surgical patients undergoing colorectal resection. Ann Surg. 1994;220(2):212-221.
39.
Decker-BaumannCBuhlKFrohmüllerSvon HerbayADueckMSchlagPM. Reduction of chemotherapy-induced side-effects by parenteral glutamine supplementation in patients with metastatic colorectal cancer. Eur J Cancer. 1999;35(2):202-207.
40.
DanieleBPerroneFGalloC. Oral glutamine in the prevention of fluorouracil induced intestinal toxicity: a double blind, placebo controlled, randomised trial. Gut. 2001;48(1):28-33.
41.
MorlionBJStehlePWachtlerP. Total parenteral nutrition with glutamine dipeptide after major abdominal surgery: a randomized, double-blind, controlled study. Ann Surg. 1998;227(2):302-308.
42.
AlivizatosVAthanasopoulosPMakrisNKarageorgosN. Early postoperative glutamine-supplemented parenteral nutrition versus enteral immunonutrition in cancer patients undergoing major gastrointestinal surgery. J BUON. 2005;10(1):119-122.
43.
BlassSCGoostHTolbaRH. Time to wound closure in trauma patients with disorders in wound healing is shortened by supplements containing antioxidant micronutrients and glutamine: a PRCT. Clin Nutr. 2012;31(4):469-475.
44.
OguzMKeremMBedirliA. L-alanin-L-glutamine supplementation improves the outcome after colorectal surgery for cancer. Colorectal Dis. 2007;9(6):515-520.
45.
SandiniMNespoliLOldaniMBernasconiDPGianottiL. Effect of glutamine dipeptide supplementation on primary outcomes for elective major surgery: systematic review and meta-analysis. Nutrients. 2015;7(1):481-499.
46.
WischmeyerPEDhaliwalRMcCallMZieglerTRHeylandDK. Parenteral glutamine supplementation in critical illness: a systematic review. Crit Care. 2014;18(2):R76.
47.
RodasPCRooyackersOHebertCNorbergÅWernermanJ. Glutamine and glutathione at ICU admission in relation to outcome. Clin Sci. 2012;122(pt 12):591-597.
48.
Oudemans-van StraatenHMBosmanRJTreskesMvan der SpoelHJZandstraDF. Plasma glutamine depletion and patient outcome in acute ICU admissions. Intensive Care Med. 2001;27(1):84-90.
49.
WischmeyerPE. Glutamine: role in critical illness and ongoing clinical trials. Curr Opin Gastroenterol. 2008;24(2):190-197.
50.
AndrewsPJDAvenellANobleDW. Randomised trial of glutamine, selenium, or both, to supplement parenteral nutrition for critically ill patients. BMJ. 2011;342:d1542.
51.
WernermanJKirketeigTAnderssonB. Scandinavian glutamine trial: a pragmatic multi-centre randomised clinical trial of intensive care unit patients. Acta Anaesthesiol Scand. 2011;55(7):812-818.
52.
BollhalderLPfeilAMTomonagaYSchwenkglenksM. A systematic literature review and meta-analysis of randomized clinical trials of parenteral glutamine supplementation. Clin Nutr. 2013;32(2):213-223.
53.
HeylandDMuscedereJWischmeyerPE. A randomized trial of glutamine and antioxidants in critically ill patients. N Engl J Med. 2013;368(16):1489-1497.
54.
ZieglerTRMayAKHebbarG. Efficacy and safety of glutamine-supplemented parenteral nutrition in surgical ICU patients: an American multicenter randomized controlled trial. Ann Surg. 2016;263(4):646-655.
55.
van ZantenAHSztarkFKaisersUX. High-protein enteral nutrition enriched with immune-modulating nutrients vs standard high-protein enteral nutrition and nosocomial infections in the ICU: a randomized clinical trial. JAMA. 2014;312(5):514-524.
56.
van ZantenARHDhaliwalRGarrelDHeylandDK. Enteral glutamine supplementation in critically ill patients: a systematic review and meta-analysis. Crit Care. 2015;19(1):294.
LinJ-JChungX-JYangC-YLauH-L. A meta-analysis of trials using the intention to treat principle for glutamine supplementation in critically ill patients with burn. Burns. 2013;39(4):565-570.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
